SEQUEL
Aguardando apresentação ou exame de recurso contra o deferimento parcial de Designação Recebida
Marca Nominativa depositada no INPI em
18/08/2023 por DEKA Research & Development Corp.,
processo nº 501762348, nas classes 05, 09, 10, 35, 41, 42, 44.
O processo ainda está em andamento no INPI.
| Número do processo | 501762348 |
|---|
| Situação | Aguardando apresentação ou exame de recurso contra o deferimento parcial de Designação Recebida |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 18/08/2023 |
|---|
| Data da concessão | — |
|---|
| Vigência até | 18/08/2033 |
|---|
| Titular | DEKA Research & Development Corp. |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · US |
|---|
Classes e especificação
Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices, all of the foregoing for use in connection with a device for the delivery of therapeutic agents for the treatment of disease, all of the foregoing expressly not related to tampons, feminine sanitary napkins, panty liners, and feminine hygiene products.;
Software as a Medical Device (SaMD), downloadable, forpredicting blood analyte levels and adjusting infusion pumpsettings based on personalized data for use in connection witha device for the delivery of therapeutic agents for the treatmentof disease; downloadable educational mobile applicationsfeaturing information and instruction on managing, treating andliving with chronic disease; batteries; battery chargers.;
Medical devices, namely, infusion and injection devices for administering therapeutic agents for the treatment of disease; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time for the treatment of disease; medical apparatus for monitoring blood analyte levels for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; implantable subcutaneous devices for the delivery of therapeutic agents for the treatment of disease, sold empty in the nature of medical fluid injectors; on-body medical fluid injectors for the delivery of therapeutic agents for the treatment of disease; chronic disease management devices in the nature of medical sensors for use in connection with a device for the delivery of therapeutic agents for the treatment of disease that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor, all used for the delivery of therapeutic agents for the treatment of disease, all of the foregoing expressly not related to tampons, feminine sanitary napkins, panty liners, and feminine hygiene products.;
Providing a trade-in program for drug delivery and chronicdisease management devices; pharmaceutical services,namely, mail order pharmacy services and processing onlineand telephone prescription orders in retail and central fillpharmacies featuring chronic disease management supplies,medications, drugs and other prescriptions.;
Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets, all of the foregoing expressly not related to tampons, feminine sanitary napkins, panty liners, and feminine hygiene products.;
Software-as-a-service (SAAS) featuring software for use in theacquisition, capture, processing, presentation, transmissionand storage of medical and physiological data obtained fromsite featuring technology that enables users to enter, access,track, monitor and generate health and medical informationand reports relating to managing chronic disease, medicationand analyte levels: upgrading of computer software, namely,Software as a Medical Device (SaMD) for predicting bloodanalyte levels and adjusting infusion pump settings based onpersonalized data for use in connection with a device for thedelivery of therapeutic agents for the treatment of disease.;
Interactive medical monitoring and alert services for remindinginfusion pump users of medicinal dosage for medical treatmentpurposes in the nature of monitoring and managing chronicdisease; providing medical information to infusion pumpusers for use in connection with a device for the delivery oftherapeutic agents for the treatment of disease in the form ofreports in the field of chronic disease management; providinga website featuring general medical information related tochronic diseases, including advice on treatment options andchronic disease management; providing online searchablemedical databases in the field of chronic disease managementfor patients, their families and caregivers, and healthcarepractitioners; medical consultation services, namely, patientambassador program to communicate medical informationto people with chronic disease, all of the foregoing related touse of a device for the delivery of therapeutic agents for thetreatment of disease.;